Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

M
2018-01-19
BHVNBiohaven Pharmaceutical Holding Co Ltd.Bailey GregoryDirS - Sale$30.76-49,0002,541,101-2%-$1,507,459
D
2018-01-23
AMRNAmarin Corp PlcukKetchum Steven BChief Scientific OfficerS - Sale+OE$4.41-135,205141,797-49%-$596,430
M
2018-01-22
COLLCollegium Pharmaceutical, IncHeffernan Michael ThomasCOB, Pres, CEOS - Sale$25.01-20,0001,054,382-2%-$500,164
DM
2018-01-19
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, CROS - Sale+OE$158.66-46,17252,260-47%-$7,325,400
2018-01-23
AGIOAgios Pharmaceuticals IncCelgene Corp /de/10%P - Purchase$67.00+851,1546,718,433+15%+$57,027,318
M
2018-01-11
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.05+23,00024,740,1890%+$1,261
2018-01-22
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$4.40+100,000187,889,4560%+$439,675
D
2018-01-22
SUPNSupernus Pharmaceuticals IncBhatt Padmanabh P.SVP of IP, CSOS - Sale+OE$48.04-20,00012,500-62%-$960,716
2018-01-18
MRNSMarinus Pharmaceuticals IncCashman Christopher MichaelCEOS - Sale$6.28-9,566247,903-4%-$60,074
D
2018-01-19
LGNDLigand Pharmaceuticals IncHiggins John LCEOS - Sale+OE$153.70-28,099134,200-17%-$4,318,902
M
2018-01-18
CBAYCymabay Therapeutics, Inc.Emster Kurt VonDirS - Sale$10.25-144,216951,951-13%-$1,477,669
2018-01-18
BGNEBeigene, Ltd.Baker Bros. Advisors LPDir, 10%P - Purchase$101.00+1,980,19884,830,765+2%+$199,999,998
2018-01-18
WIZPWize Pharma, Inc.Zarachia Yaakov10%P - Purchase$0.12+5,00012,371,8920%+$600
D
2018-01-18
KPTIKaryopharm Therapeutics Inc.Shacham SharonPres, CSOS - Sale+OE$10.09-10,0001,320,271-1%-$100,882
D
2018-01-18
KPTIKaryopharm Therapeutics Inc.Kauffman MichaelCEOS - Sale+OE$10.09-10,0001,320,271-1%-$100,882
2018-01-18
KERXKeryx Biopharmaceuticals IncCarberry Christine A.COOS - Sale$4.87-9,04875,952-11%-$44,064
2018-01-17
STMLStemline Therapeutics IncGionco DavidChief Accounting OfficerS - Sale$13.43-4,250162,538-3%-$57,078
D
2018-01-18
FGENFibrogen IncRosenkranz Roberto PedroDirS - Sale+OE$47.45-6,00037,000-14%-$284,695
M
2018-01-18
FGENFibrogen IncNeff Thomas BCEOS - Sale$47.46-38,6363,163,757-1%-$1,833,514
D
2018-01-18
FGENFibrogen IncKurkijarvi KaleviDirS - Sale+OE$47.38-6,00022,000-21%-$284,268
DM
2018-01-03
BDSIBiodelivery Sciences International IncSirgo Mark ADirS - Sale+OE$2.73-709,5022,300,661-24%-$1,938,961
2018-01-19
COLLCollegium Pharmaceutical, IncHeffernan Michael ThomasCOB, Pres, CEOS - Sale$22.50-20,000538,987-4%-$450,000
AM
2018-01-12
MRKMerck & Co., Inc.Graddick Weir Mirian MExe V-P, HRS - Sale$61.20-68,00090,484-43%-$4,161,800
M
2018-01-16
WIZPWize Pharma, Inc.Zarachia Yaakov10%P - Purchase$0.15+23,00012,366,8920%+$3,394
2017-12-27
CUECue Biopharma, Inc.Pienta KennethChief Medical OfficerP - Purchase$7.50+2,0002,000New+$15,000
M
2018-01-17
BLCMBellicum Pharmaceuticals, IncBaker Bros. Advisors LP10%S - Sale$8.20-880,73558,131-94%-$7,219,895
M
2018-01-18
ALIMAlimera Sciences IncMyers C. DanielCEOS - Sale$1.20-52,90075,061-41%-$63,379
M
2018-01-18
ALIMAlimera Sciences IncHolland DavidSVP of Sales, MarketingS - Sale$1.20-25,500109,588-19%-$30,552
M
2018-01-18
ALIMAlimera Sciences IncGreen KennethSVP, Chief Scientific OfficerS - Sale$1.20-10,638170,634-6%-$12,742
M
2018-01-18
ALIMAlimera Sciences IncEiswirth Richard S JrPres, CFOS - Sale$1.20-13,41077,970-15%-$16,063
M
2018-01-18
ALIMAlimera Sciences IncAshman PhilipSVP, EU MDS - Sale$1.20-25,5000-100%-$30,552
M
2018-01-17
CNCEConcert Pharmaceuticals, Inc.Aldrich RichardDirS - Sale$19.35-30,000349,380-8%-$580,400
2018-01-18
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.25+5,0004,308,2410%+$1,250
D
2018-01-16
CYTKCytokinetics IncMcDowell Caryn GordonGC, Chief Compliance OfficerS - Sale+OE$9.00-2,70915,000-15%-$24,381
2018-01-16
MBVXMabvax Therapeutics Holdings, Inc.Maffuid Paul WEVPS - Sale$0.92-38,054283,703-12%-$35,010
2018-01-16
MBVXMabvax Therapeutics Holdings, Inc.Hansen John DavidPres, CEOS - Sale$0.92-59,263536,730-10%-$54,522
2018-01-16
MBVXMabvax Therapeutics Holdings, Inc.Resnick Paul FVP, CBOS - Sale$0.92-3,07118,333-14%-$2,825
2018-01-16
MBVXMabvax Therapeutics Holdings, Inc.Hanson Gregory PCFO, SECRS - Sale$0.92-41,873320,013-12%-$38,523
D
2018-01-17
GBTGlobal Blood Therapeutics, Inc.Choi JungSee RemarksS - Sale+OE$52.85-3,000159,778-2%-$158,550
M
2018-01-16
BHVNBiohaven Pharmaceutical Holding Co Ltd.Doogan DeclanDirS - Sale$26.95-128,0581,859,915-6%-$3,451,297
2018-01-16
BHVNBiohaven Pharmaceutical Holding Co Ltd.Bailey GregoryDirS - Sale$26.52-40,0002,590,101-2%-$1,060,800
M
2018-01-16
CORICorium International, Inc.Perceptive Advisors LLC10%P - Purchase$12.54+510,0006,357,133+9%+$6,395,357
DM
2018-01-16
MGNXMacrogenics IncWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-5,00030,000-14%-$100,000
2018-01-16
JAZZJazz Pharmaceuticals PlcYoung Matthew P.EVP, CFOS - Sale$152.16-70038,959-2%-$106,512
D
2018-01-16
LOXOLoxo Oncology, Inc.Burstein JenniferSVP of FinanceS - Sale+OE$87.50-1,5000-100%-$131,243
DM
2018-01-16
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerS - Sale+OE$88.21-3,0820-100%-$271,866
DM
2018-01-16
LOXOLoxo Oncology, Inc.Bilenker Joshua H.Pres, CEOS - Sale+OE$88.21-15,000182,707-8%-$1,323,099
D
2018-01-16
MRTXMirati Therapeutics, Inc.Christensen JamieSVP, Chief Science OfficerS - Sale+OE$27.00-10,8142,877-79%-$291,978
M
2018-01-16
ALIMAlimera Sciences IncHolland DavidSVP of Sales, MarketingS - Sale$1.23-25,500135,088-16%-$31,475
M
2018-01-16
ALIMAlimera Sciences IncGreen KennethSVP, Chief Scientific OfficerS - Sale$1.23-11,489181,272-6%-$14,181
M
2018-01-16
ALIMAlimera Sciences IncAshman PhilipSVP, EU MDS - Sale$1.23-25,50025,500-50%-$31,475
M
2018-01-16
ALIMAlimera Sciences IncMyers C. DanielCEOS - Sale$1.23-52,900127,961-29%-$65,294
M
2018-01-16
ALIMAlimera Sciences IncEiswirth Richard S JrPres, CFOS - Sale$1.23-14,49491,380-14%-$17,890
D
2018-01-16
CNCEConcert Pharmaceuticals, Inc.Aldrich RichardDirS - Sale+OE$19.14-31,236364,380-8%-$597,833
2018-01-16
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%S - Sale$1.51-150,60321,837,610-1%-$227,583
D
2018-01-16
IONSIonis Pharmaceuticals IncKlein Joseph IIIDirS - Sale+OE$52.52-3,00010,039-23%-$157,566
D
2018-01-16
IONSIonis Pharmaceuticals IncGeary Richard SSVP, DevelopmentS - Sale+OE$51.76-2,72316,680-14%-$140,942
D
2018-01-16
IONSIonis Pharmaceuticals IncParshall B LynneDirS - Sale+OE$51.76-5,98638,180-14%-$309,835
D
2018-01-16
IONSIonis Pharmaceuticals IncO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$51.76-2,69714,452-16%-$139,597
D
2018-01-16
IONSIonis Pharmaceuticals IncBoyce SarahChief Business OfficerS - Sale+OE$51.76-2,1968,931-20%-$113,665
D
2018-01-16
IONSIonis Pharmaceuticals IncBennett C FrankSVP, Antisense ResearchS - Sale+OE$51.76-2,69619,114-12%-$139,545
D
2018-01-15
IONSIonis Pharmaceuticals IncCrooke Stanley TCOB, CEOS - Sale+OE$51.76-16,549781,252-2%-$856,576
D
2018-01-16
IONSIonis Pharmaceuticals IncMonia Brett PCOOS - Sale+OE$51.76-2,82115,783-15%-$146,015
D
2018-01-17
SUPNSupernus Pharmaceuticals IncVaughn VictorSVP of SalesS - Sale+OE$46.26-24,2509,344-72%-$1,121,750
D
2018-01-17
SUPNSupernus Pharmaceuticals IncBhatt Padmanabh P.SVP of IP, CSOS - Sale+OE$44.98-20,00012,500-62%-$899,500
M
2018-01-12
AMRNAmarin Corp PlcukKennedy Joseph TGCS - Sale$4.10-51,1060-100%-$209,450
D
2018-01-17
ARRYArray Biopharma IncVan Lunsen Gil JDirS - Sale+OE$12.94-21,50019,297-53%-$278,210
2018-01-12
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickEVP, US CommercialS - Sale$148.65-20021,669-1%-$29,730
2018-01-12
JAZZJazz Pharmaceuticals PlcCozadd Bruce CCOB, CEOS - Sale$150.00-3,000273,737-1%-$450,000
2018-01-16
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$156.99-56,25049,761-53%-$8,830,755
2018-01-16
CLVSClovis Oncology, Inc.Ivers-Read Gillian CSee RemarksS - Sale$59.16-3,000183,571-2%-$177,480
D
2018-01-16
VRTXVertex Pharmaceuticals Inc / MaLeiden Jeffrey MCEO, PresS - Sale+OE$156.99-99,563132,937-43%-$15,630,614
D
2018-01-16
VRTXVertex Pharmaceuticals Inc / MaSmith Ian FEVP, COOS - Sale+OE$157.29-2,12546,194-4%-$334,232
D
2018-01-16
VRTXVertex Pharmaceuticals Inc / MaChodakewitz JeffreyEVP GMDA, CMOS - Sale+OE$157.28-1,71954,424-3%-$270,358
D
2018-01-16
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale+OE$158.28-2,12542,092-5%-$336,345
D
2018-01-16
PTGXProtagonist Therapeutics, IncLiu David YChief Scientific OfficerS - Sale+OE$20.00-8753,822-19%-$17,500
D
2018-01-16
GTHXG1 Therapeutics, Inc.Velleca Mark A.Pres, CEOS - Sale+OE$22.99-7,5000-100%-$172,395
D
2018-01-16
GTHXG1 Therapeutics, Inc.Malik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$22.96-3,7760-100%-$86,693
D
2018-01-12
MYOKMyokardia IncGianakakos AnastasiosPres, CEOS - Sale+OE$50.00-5,000690,286-1%-$250,000
2018-01-12
MYOKMyokardia IncLambing JosephSee RemarksS - Sale$50.00-5,00095,846-5%-$250,000
D
2018-01-11
ALKSAlkermes Plc.Cooke ShanePres, Alkermes plcS - Sale+OE$60.22-6,20774,708-8%-$373,809
DM
2018-01-12
AIMTAimmune Therapeutics, Inc.Adelman Daniel C MdChief Medical OfficerS - Sale+OE$40.00-36,7170-100%-$1,468,680
D
2018-01-11
AMRNAmarin Corp PlcukKetchum Steven BChief Scientific OfficerS - Sale+OE$4.40-2,612141,797-2%-$11,493
D
2018-01-16
AGIOAgios Pharmaceuticals IncSchenkein David PCEOS - Sale+OE$73.16-53,000350,854-13%-$3,877,218
D
2018-01-16
MRKMerck & Co., Inc.Schechter Adam HEVP, Pres-Global Human HealthS - Sale+OE$61.63-101,60262,766-62%-$6,261,731
2018-01-16
MRKMerck & Co., Inc.Holston Michael JEVP, GCS - Sale$61.63-12,50049,092-20%-$770,375
DM
2018-01-12
MRKMerck & Co., Inc.Graddick Weir Mirian MExe V-P, HRS - Sale+OE$61.35-65,00093,484-41%-$3,987,800
D
2018-01-12
VRTXVertex Pharmaceuticals Inc / MaParini MichaelEVP, CL, AOS - Sale+OE$157.16-2,12528,943-7%-$333,965
D
2018-01-12
SUPNSupernus Pharmaceuticals IncVaughn VictorSVP of SalesS - Sale+OE$45.03-5,7509,344-38%-$258,928
D
2018-01-16
ARRYArray Biopharma IncHaddock JasonCFOS - Sale+OE$13.73-7,50028,868-21%-$102,975
D
2018-01-12
PKTXProtokinetix, Inc.Smith Clarence EdwardPres, CEO, 10%P - Purchase$0.05+2,359,24060,976,366+4%+$117,962
M
2018-01-09
WIZPWize Pharma, Inc.Zarachia Yaakov10%P - Purchase$0.13+23,12212,343,8920%+$2,951
DM
2018-01-10
MBVXMabvax Therapeutics Holdings, Inc.Hanson Gregory PCFO, SECRS - Sale+OE$0.97-116,479361,886-24%-$112,594
DM
2018-01-10
MBVXMabvax Therapeutics Holdings, Inc.Resnick Paul FVP, CBOS - Sale+OE$0.97-8,54021,404-29%-$8,255
DM
2018-01-10
MBVXMabvax Therapeutics Holdings, Inc.Maffuid Paul WEVPS - Sale+OE$0.97-105,851321,757-25%-$102,320
DM
2018-01-10
MBVXMabvax Therapeutics Holdings, Inc.Livingston Philip O.CHIEF SCIENCE OFFICERS - Sale+OE$0.97-37,027256,554-13%-$35,792
DM
2018-01-10
MBVXMabvax Therapeutics Holdings, Inc.Hansen John DavidPres, CEOS - Sale+OE$0.97-192,690595,993-24%-$186,263
2018-01-08
STMLStemline Therapeutics IncHoberman KennethCOOS - Sale$13.93-14,040384,792-4%-$195,577
M
2018-01-11
CBISCannabis Science, Inc.Tam Benjamin C.K.CFOS - Sale$0.10-193,6264,806,374-4%-$19,369
M
2018-01-10
BHVNBiohaven Pharmaceutical Holding Co Ltd.Doogan DeclanDirS - Sale$26.78-121,9421,178,058-9%-$3,265,537

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top